Marshall Wace North America’s Syneron Medical Ltd ELOS Stock Holding History

Marshall Wace North America’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-208,901	Closed	-$2.3M	–	1702
2017 Q2	$2.3M	Buy	+208,901	New	+$2.29M	0.02%	713

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Marshall Wace North America's ELOS Position: Q3 2017 in Review

Marshall Wace North America sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 208,901 shares — an estimated $2.3M sold.

Marshall Wace North America first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $2.3M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

Marshall Wace North America reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
Marshall Wace North America sold 208,901 Syneron Medical Ltd shares in Q3 2017, an estimated $2.3M.
Marshall Wace North America first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
Marshall Wace North America's Syneron Medical Ltd position peaked at $2.3M in Q2 2017.
4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Marshall Wace North America's 13F filing for Q3 2017, filed 13 Nov 2017.